Clinical Research

RSS icon
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

TAVR specialists come together to explore new data, patient selection and much more

Care teams have a lot to consider when choosing the right treatment for patients with severe aortic stenosis. Two cardiologists and a veteran cardiothoracic surgeon are taking part in a new webinar focused on that very topic. 

Paul Ridker, MD, MPH, Eugene Braunwald Professor of Medicine at Harvard Medical School, and Director of the Center for Cardiovascular Disease Prevention, at Brigham and Women’s Hospital, explains the role of high sensitivity C-reactive protein (hs-CRP) in detecting coronary inflammation and the opportunities to improve outcomes with targeted therapies.

Inflammation playing a much bigger role in heart disease evaluations

From new drug therapies and imaging technologies to updated prevention strategies, nearly every aspect of cardiovascular care is starting to embrace the value of coronary inflammation evaluations. Paul Ridker, MD, MPH, discussed the trend in a new interview.

soda soft drink coke

Drinking sugar ‘more problematic’ than eating it: Soda, fruit juice linked to high diabetes risk

“Rather than condemning all added sugars, future dietary guidelines might consider the differential effects of sugar based on its source and form," one researcher said.

Rishi Wadhera, MD, MPP, MPhil, associate director of the Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, and associate professor of medicine at Harvard Medical School, Explains a report showing socioeconomic factors are driving increased cardiovascular death rates, especially in younger adults, and urges action to address these health disparities.

Death from heart disease more common in rural areas—what can cardiologists do?

Rishi Wadhera, MD, detailed new data that show how socioeconomic factors are driving cardiovascular death rates, especially in younger adults.

Mario Gaudino, MD, explains why cardiac surgery trials need more diversity to better inform treatment decisions for women and minorities.

The lack of diversity in cardiac surgery trials may be harmful to patients

Mario Gaudino, MD, PhD, told Cardiovascular Business there is a major need for more women and minorities in today's clinical trials.

Video interview with Mario Gaudino on trends in cardiac surgery.

Veteran surgeon unpacks major changes in the world of cardiac surgery

Mario Gaudino, MD, PhD, spoke to Cardiovascular Business about minimally invasive procedures, the growing interest in clinical trials and other key trends in the world of cardiac surgery.

Predictive model helps identify malignancy in thyroid nodules.

Predictive model uses 6 ultrasound features to differentiate between benign and malignant thyroid nodules

Once the model is further validated, it could help guide providers in determining how to manage thyroid nodules. 

cardiologists heart doctors

Early TAVR or SAVR in asymptomatic patients linked to improved survival, reduced costs

Researchers explored data from more than 24,000 AVR patients, presenting their findings at EuroPCR in Paris.

Displaying 65 - 72 of 927
Design by Adaptive Theme